BLISSGVS
Invest Now

Bliss GVS Pharma Share Price
₹121.17 -2.93 (-2.36%)
26 Mar, 2025 21:26
Start SIP in
BLISSGVS
Performance
- Low
- ₹120
- High
- ₹125
- 52 Week Low
- ₹92
- 52 Week High
- ₹186
- Open Price₹124
- Previous Close₹124
- Volume414,656
Investment Returns
- Over 1 Month -10.42%
- Over 3 Month -24.23%
- Over 6 Month -11.63%
- Over 1 Year + 4.73%
Smart Investing Starts Here Start SIP with Bliss GVS Pharma for Steady Growth!
Bliss GVS Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 21.4
- PEG Ratio
- -0.7
- Market Cap Cr
- 1,277
- P/B Ratio
- 1.3
- Average True Range
- 6.38
- EPS
- 7.63
- Dividend Yield
- 0.4
- MACD Signal
- -6.04
- RSI
- 42.85
- MFI
- 59.84
Bliss GVS Pharma Financials
Bliss GVS Pharma Technicals
EMA & SMA
Current Price
₹121.17
-2.93
(-2.36%)

-
- Bearish Moving Average 15
-
- Bullish Moving Average 1
- 20 Day
- ₹123.98
- 50 Day
- ₹133.56
- 100 Day
- ₹137.52
- 200 Day
- ₹133.49
Resistance and Support
122.08
- R3 128.95
- R2 126.96
- R1 124.07
- S1 119.19
- S2 117.20
- S3 114.31
Bliss GVS Pharma Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-01-28 | Quarterly Results & Others | To consider other business matters. per share(50%)Dividend |
2024-10-24 | Quarterly Results | |
2024-07-24 | Quarterly Results | |
2024-05-02 | Audited Results & Final Dividend | |
2024-01-23 | Quarterly Results |
Bliss GVS Pharma F&O
About Bliss GVS Pharma
- NSE Symbol
- BLISSGVS
- BSE Symbol
- 506197
- Managing Director
- Mr. Gagan Harsh Sharma
- ISIN
- INE416D01022
Similar Stocks to Bliss GVS Pharma
Bliss GVS Pharma FAQs
Bliss GVS Pharma share price is ₹121 As on 26 March, 2025 | 21:12
The Market Cap of Bliss GVS Pharma is ₹1276.8 Cr As on 26 March, 2025 | 21:12
The P/E ratio of Bliss GVS Pharma is 21.4 As on 26 March, 2025 | 21:12
The PB ratio of Bliss GVS Pharma is 1.3 As on 26 March, 2025 | 21:12
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.